Elevance Health (ELV) Payables (2009 - 2026)

Elevance Health (ELV) has 18 years of Payables data on file, last reported at $6.9 billion in Q1 2026.

• Payables for Q1 2026 came in at $6.9 billion, down 6.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 billion (down 6.07% YoY), and the FY2025 annual result was $7.5 billion, up 2.47% from the prior year.
• Payables declined to $6.9 billion in Q1 2026 per ELV's latest filing, from $7.5 billion in the prior quarter.
• Over five years, Payables peaked at $7.6 billion in Q2 2025 and troughed at $5.1 billion in Q1 2023.
• A 5-year average of $6.4 billion and a median of $6.3 billion in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2024: Payables slipped 14.78% in 2022, then surged 40.77% in 2024.
• A 5-year view of Payables shows it stood at $5.9 billion in 2022, then climbed by 21.51% to $7.1 billion in 2023, then increased by 2.2% to $7.3 billion in 2024, then gained by 2.47% to $7.5 billion in 2025, then decreased by 7.21% to $6.9 billion in 2026.
• Business Quant data shows ELV's Payables at $6.9 billion in Q1 2026, $7.5 billion in Q4 2025, and $6.3 billion in Q3 2025.